The long-term objective of this SCOR is to further our understanding of the pathogenesis of idiopathic pulmonary fibrosis (IPF), and ultimately to develop new treatment strategies for this disease. The general hypothesis is that the initiation and resolution of inflammatory and immune processes in the lung involve bidirectional regulatory interactions between leukocytes and cells of the alveolar-capillary wall. We contend that these interactions are major factors in determining the persistence of inflammation and progression to pulmonary fibrosis. The specific hypotheses are: 1. Cytokine networks regulating inflammation and repair are disrupted in IPF. These abnormalities are most evident when directly examining lung tissue, rather than bronchoalveolar cells or alveolar fluid. 2. Pulmonary immune responses are compartmentalized in the lung. Dendritic cells initiate antigen processing in the interstitium, but become immunostimulatory in lymphoid tissue. Alveolar epithelial cells actively participate in immune responses by elaborating a lymphocyte suppressive factor. 3. Alveolar epithelial cells actively participate in regulating the appropriate clearance of parenchymal fibrin deposits in the inflamed alveolus. This is likely achieved by expression of a plasminogen activator (PA), a PA inhibitor, and a cell surface PA receptor. 4. Cytokines induce alterations in pulmonary endothelial cells which augment lymphocyte recruitment in inflammatory lung diseases. The basis for altered lymphocyte recruitment can be elucidated by characterization of a lung-specific lymphocyte homing receptor. 5. Interactions between alveolar macrophages and alveolar epithelial cells regulate phospholipase and cyclooxygenase enzymes of both cell types, thereby controlling the production of eicosanoids that modulate inflammation, immune function, and fibrogenesis. This SCOR will take a multidisciplinary approach to testing these hypotheses, bringing to bear the expertise of investigators trained in internal medicine, pathology, cell and molecular biology, biochemistry, and biostatistics. The strengths of this proposal are the investigators' long- standing interests in IPF and pulmonary immunobiology, the proven commitment to collaborative research by both clinicians and basic scientists, access to a large population of IPF patients, and extraordinary institutional resources for biomedical research.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL046487-04
Application #
2222965
Study Section
Special Emphasis Panel (SRC (MA))
Project Start
1992-02-05
Project End
1996-11-30
Budget Start
1994-12-01
Budget End
1995-11-30
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Flaherty, Kevin R; King Jr, Talmadge E; Raghu, Ganesh et al. (2004) Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 170:904-10
Flaherty, Kevin R; Colby, Thomas V; Travis, William D et al. (2003) Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 167:1410-5
Flaherty, Kevin R; Mumford, Jeanette A; Murray, Susan et al. (2003) Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168:543-8
Lama, Vibha N; Flaherty, Kevin R; Toews, Galen B et al. (2003) Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168:1084-90
Flaherty, K R; Thwaite, E L; Kazerooni, E A et al. (2003) Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 58:143-8
Flaherty, K R; Toews, G B; Travis, W D et al. (2002) Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 19:275-83
Flaherty, K R; Wald, J; Weisman, I M et al. (2001) Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 164:425-32
Lynch 3rd, J P; White, E; Flaherty, K (2001) Corticosteroids in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 7:298-308
Flaherty, K R; Kazerooni, E A; Curtis, J L et al. (2001) Short-term and long-term outcomes after bilateral lung volume reduction surgery : prediction by quantitative CT. Chest 119:1337-46
Flaherty, K R; Travis, W D; Colby, T V et al. (2001) Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164:1722-7

Showing the most recent 10 out of 142 publications